Form 4: Adage Capital Sells Solid Biosciences Shares

Adage Capital Management, a 10% owner of Solid Biosciences, sold 252,545 shares of common stock at an average price of $7.56 on February 18, 2025.

Summary

• Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, filed a Form 4 regarding a transaction in Solid Biosciences Inc. [SLDB] stock.
• On February 18, 2025, Adage Capital Management sold 252,545 shares of Solid Biosciences common stock at a weighted average price of $7.56.
• The price range for the shares sold was between $7.22 and $7.75.
• Following the transaction, Adage Capital Partners, L.P. indirectly holds 4,248,084 shares.
• Adage Capital Management, L.P. serves as the investment manager of Adage Capital Partners, L.P. and has discretion over the portfolio securities held by ACP.
• Robert Atchinson and Phillip Gross are managing members of entities that manage and are general partners of Adage Capital Partners, L.P. and Adage Capital Management, L.P.

Sentiment

Score: 5

Explanation: Neutral. This is a routine transaction disclosure. The sale itself could be interpreted as slightly negative, but without further context, it's difficult to assess the overall impact.

Negatives

• Adage Capital Management reduced its holdings in Solid Biosciences by selling 252,545 shares.

Industry Context

This transaction reflects investment portfolio management activity by a major shareholder in a biotechnology company. It's important to monitor such transactions as they can reflect the investor's sentiment and strategy regarding the company's future prospects.

Stakeholder Impact

• The sale of shares by a major shareholder could potentially influence investor sentiment regarding Solid Biosciences.

Key Dates